NCT01220752View on ClinicalTrials.gov

Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 17, 2011

Primary Completion Date

August 29, 2019

Study Completion Date

December 19, 2021

Conditions
Sinonasal MalignanciesAdenocarcinoma and Squamous Cell Carcinoma of the Paranasal Sinuses
Interventions
RADIATION

carbon ion boost

8 fractions carbon ion (8 x 3 GyE C12) therapy followed by 25 fractions of IMRT corresponding to a total dose of approximately 74 GyE. Treatment duration is approximately 61/2-7 weeks

Trial Locations (1)

69120

Dept of Radiation Oncology, University of Heidelberg, INF 400, Heidelberg

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT01220752 - Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12) | Biotech Hunter | Biotech Hunter